Press releases

Older releases

Latest reports

All reports

Calendar

All events

Share

Read more

Initiator Pharma Numbers

  • Number of men affected by Erectile Dysfunction worldwide 150 million
  • Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 150000
  • Men with Erectile Dysfunction who do not respond to drug therapy 40 %
Initiatorpharma-module-homepage-1-22102021

Initiator Pharma currently has a portfolio of four projects, of which two are in clinical development and two are in preclinical development.

View our Pipeline

CEO letter

With a plan for secured financing, an attractive portfolio of clinical assets progressing according to plan, and our latest management team member Christina Guldberg onboard as Senior Director, Clinical Development and Outcomes Research (Rare Diseases), a new position designed to strengthen our clinical development and Orphan drug capabilities, I see the future with confidence and look forward to keep you updated on our progress.

Read the full letter
Initiatorpharma-module-homepage-2-22102021

Mono-amine transporters is a unique class of proteins that are located just outside the synaptic cleft (peri-synaptically), transporting monoamine transmitter overflow from the synaptic cleft back to the cytoplasm of the pre-synaptic neuron.

Read more about our technology